Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Clin Exp Immunol

Retrieve available abstracts of 12 articles:
HTML format
Text format



Single Articles


    September 2017
  1. KUSAKA S, Nishida A, Takahashi K, Bamba S, et al
    Expression of Human Cathelicidin Peptide LL-37 in Inflammatory Bowel Disease.
    Clin Exp Immunol. 2017 Sep 5. doi: 10.1111/cei.13047.
    PubMed     Text format     Abstract available


    August 2017
  2. NISSILA E, Korpela K, Lokki AI, Paakkanen R, et al
    C4B gene influences intestinal microbiota through complement activation in patients with Pediatric-Onset Inflammatory Bowel Disease.
    Clin Exp Immunol. 2017 Aug 23. doi: 10.1111/cei.13040.
    PubMed     Text format     Abstract available


    December 2016
  3. HORJUS TALABUR HORJE CS, Smids C, Meijer JW, Groenen MJ, et al
    High endothelial venules associated with T cell subsets in the inflamed gut of newly diagnosed Inflammatory Bowel Disease patients.
    Clin Exp Immunol. 2016 Dec 29. doi: 10.1111/cei.12918.
    PubMed     Text format     Abstract available


    November 2016
  4. SUN M, He C, Wu W, Zhou G, et al
    Hypoxia inducible factor-1alpha-induced interleukin-33 expression in intestinal epithelia contributes to mucosal homeostasis in inflammatory bowel disease.
    Clin Exp Immunol. 2016 Nov 7. doi: 10.1111/cei.12896.
    PubMed     Text format     Abstract available


    October 2016
  5. KOOIJ IA, Sahami S, Meijer SL, Buskens CJ, et al
    The immunology of the vermiform appendix: a review of the literature.
    Clin Exp Immunol. 2016;186:1-9.
    PubMed     Text format     Abstract available


    May 2016
  6. YANG GX, Sun Y, Tsuneyama K, Zhang W, et al
    Endogenous IL-22 protects against inflammatory bowel disease but not autoimmune cholangitis in dnTGF-betaRII mice.
    Clin Exp Immunol. 2016 May 5. doi: 10.1111/cei.12806.
    PubMed     Text format     Abstract available


    March 2016
  7. MARTINEZ-CHAMORRO A, Moreno A, Gomez-Garcia M, Cabello MJ, et al
    MICA*A4 protects against Ulcerative Colitis whereas MICA*A5.1 is associated with abscesses formation and the age on onset.
    Clin Exp Immunol. 2016 Mar 3. doi: 10.1111/cei.12786.
    PubMed     Text format     Abstract available


    December 2015
  8. BOUTET MA, Bart G, Penhoat M, Amiaud J, et al
    Distinct Expression of IL-36alpha, beta, gamma, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.
    Clin Exp Immunol. 2015 Dec 23. doi: 10.1111/cei.12761.
    PubMed     Text format     Abstract available


  9. GURRAM B, Salzman NH, Kaldunski ML, Jia S, et al
    Plasma induced signatures reveal an extracellular milieu possessing an immunoregulatory bias in treatment-naive pediatric inflammatory bowel disease.
    Clin Exp Immunol. 2015 Dec 13. doi: 10.1111/cei.12753.
    PubMed     Text format     Abstract available


    October 2015
  10. FERNANDES P, MacSharry J, Darby T, Fanning A, et al
    Differential expression of key regulators of Toll-like Receptors in Ulcerative Colitis and Crohn's disease: A role for Tollip and PPARgamma?
    Clin Exp Immunol. 2015 Oct 14. doi: 10.1111/cei.12732.
    PubMed     Text format     Abstract available


    August 2015
  11. ISRAELI E, Goldin E, Fishman S, Konikoff F, et al
    Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.
    Clin Exp Immunol. 2015;181:362-72.
    PubMed     Text format     Abstract available


    July 2015
  12. BENDIX M, Dige A, Deleuran B, Dahlerup JF, et al
    Flow cytometry detection of vitamin D receptor changes during vitamin D treatment in Crohn's disease.
    Clin Exp Immunol. 2015;181:19-28.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: